Mr. YI leads Hillhouse Capital’s healthcare investment and has made investments into Wuxi AppTec, Ganlee, BeiGene, Innovent and Junshi, in addition to establishing a China JV with Mayo Clinic-Huimei Healthcare. He holds an MBA from the Marshall School of Business at University of Southern California.